Orchid Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
1,081.80
92.1 (9.31%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 5.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
59.89
59.89
119.28
109.38
109.38
109.38
Share Warrants & Outstandings
Total Reserve
1,504.42
1,494.05
1,050.19
579.27
538.00
543.53
Shareholder's Funds
1,564.31
1,553.93
1,169.47
688.65
647.38
652.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
184.74
10.03
120.43
190.40
208.17
427.50
Secured Loans
184.74
0.03
0.22
81.64
147.79
364.00
Unsecured Loans
0.00
10.00
120.21
108.75
60.38
63.50
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
3.23
3.23
3.23
Other Long Term Liabilities
4.72
0.04
0.37
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
13.45
4.70
3.63
12.60
11.01
11.54
Total Non-Current Liabilities
202.91
14.77
124.43
164.67
222.40
442.26
Current Liabilities
Trade Payables
346.71
336.16
229.58
174.37
167.68
109.95
Other Current Liabilities
26.99
26.33
14.27
11.53
10.30
25.76
Short Term Borrowings
116.70
143.31
14.05
182.51
59.79
2.84
Short Term Provisions
0.80
2.86
2.08
3.49
3.01
3.52
Total Current Liabilities
491.21
508.66
259.97
371.89
240.78
142.08
Total Liabilities
2,258.43
2,077.37
1,553.87
1,225.21
1,110.56
1,237.25
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
1,511.55
1,497.65
1,299.94
1,220.56
1,176.39
1,176.10
Less: Accumulated Depreciation
824.34
790.23
680.38
647.47
592.68
505.66
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
687.20
707.42
619.56
573.09
583.70
670.45
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
340.52
64.49
16.39
46.46
9.78
7.43
Intangible assets under development
73.08
16.22
14.28
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
66.97
59.90
45.82
44.44
45.49
0.40
Long Term Loans & Advances
156.45
131.45
66.38
60.20
73.93
5.18
Other Non Current Assets
0.02
0.02
0.02
0.00
0.01
3.94
Total Non-Current Assets
1,329.16
979.84
763.12
724.20
712.91
687.39
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
15.02
Inventories
372.31
457.37
264.23
228.74
172.66
152.89
Sundry Debtors
381.35
353.05
195.55
215.19
170.57
135.70
Cash and Bank
83.52
200.63
266.57
30.63
8.06
19.91
Other Current Assets
17.06
10.97
8.69
4.93
20.85
178.08
Short Term Loans and Advances
75.02
75.51
55.72
21.52
25.51
48.26
Total Current Assets
929.26
1,097.53
790.75
501.01
397.65
549.86
Net Current Assets (Including Current Investments)
438.05
588.87
530.78
129.12
156.87
407.78
Total Current Assets Excluding Current Investments
929.26
1,097.53
790.75
501.01
397.65
534.84
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
2,258.43
2,077.37
1,553.87
1,225.21
1,110.56
1,237.25
Contingent Liabilities
24.51
18.24
56.97
41.95
42.88
45.12
Total Debt
301.44
153.34
134.48
289.79
267.95
430.34
Book Value per share (adjusted)
993.34
986.56
217.06
151.92
141.81
143.16
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 96.58% vs 14.02% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 11,700.00% vs -89.19% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 33.14% vs 21.38% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 11.80% vs 30.73% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -15.33% vs 38.80% in Mar 2025

Compare Balance Sheet Results of Orchid Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
59.89
58.71
1.18
2.01%
Share Warrants & Outstandings
Total Reserve
1,504.42
1,739.84
-235.42
-13.53%
Shareholder's Funds
1,564.31
1,798.55
-234.24
-13.02%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
184.74
0.00
184.74
0.00%
Secured Loans
184.74
0.00
184.74
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
84.86
-84.86
-100.00%
Other Long Term Liabilities
4.72
2.40
2.32
96.67%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
13.45
10.96
2.49
22.72%
Total Non-Current Liabilities
202.91
98.22
104.69
106.59%
Current Liabilities
Trade Payables
346.71
482.56
-135.85
-28.15%
Other Current Liabilities
26.99
72.20
-45.21
-62.62%
Short Term Borrowings
116.70
132.00
-15.30
-11.59%
Short Term Provisions
0.80
3.42
-2.62
-76.61%
Total Current Liabilities
491.21
690.18
-198.97
-28.83%
Total Liabilities
2,258.43
2,586.95
-328.52
-12.70%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,511.55
1,628.02
-116.47
-7.15%
Less: Accumulated Depreciation
824.34
449.86
374.48
83.24%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
687.20
1,178.16
-490.96
-41.67%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
340.52
93.61
246.91
263.76%
Intangible assets under development
73.08
1.93
71.15
3,686.53%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
66.97
17.41
49.56
284.66%
Long Term Loans & Advances
156.45
50.84
105.61
207.73%
Other Non Current Assets
0.02
13.96
-13.94
-99.86%
Total Non-Current Assets
1,329.16
1,359.32
-30.16
-2.22%
Current Assets Loans & Advances
Current Investments
0.00
3.51
-3.51
-100.00%
Inventories
372.31
371.07
1.24
0.33%
Sundry Debtors
381.35
603.13
-221.78
-36.77%
Cash and Bank
83.52
198.36
-114.84
-57.89%
Other Current Assets
17.06
27.20
-10.14
-37.28%
Short Term Loans and Advances
75.02
24.36
50.66
207.96%
Total Current Assets
929.26
1,227.63
-298.37
-24.30%
Net Current Assets (Including Current Investments)
438.05
537.45
-99.40
-18.49%
Total Current Assets Excluding Current Investments
929.26
1,224.12
-294.86
-24.09%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
2,258.43
2,586.95
-328.52
-12.70%
Contingent Liabilities
24.51
5.66
18.85
333.04%
Total Debt
301.44
132.00
169.44
128.36%
Book Value per share (adjusted)
993.34
61.27
932.07
1,521.25%
Annual - Borrowings
Borrowings 301.44 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 96.58% vs 14.02% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.72 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11,700.00% vs -89.19% in Mar 2025

Annual - Fixed Assets
Fixed Assets 1,027.72 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 33.14% vs 21.38% in Mar 2025

Annual - Investments
Investments 66.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.80% vs 30.73% in Mar 2025

Annual - Current Assets
Current Assets 929.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -15.33% vs 38.80% in Mar 2025